TGFβ1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: Respective contribution of ALK1 and ALK5

Stem Cells

Volumn 24, Issue 11, 2006, Pages 2420-2427

  Mallet, Christine ^a   Vittet, Daniel ^b   Feige, Jean Jacques ^a   Bailly, Sabine ^a,b  

^a DIF   (France)

^b CEA GRENOBLE   (France)

Author keywords

Activin receptor like kinase 1; Activin receptor like kinase 5; Angiogenesis; Embryonic stem cells; Transforming growth factor 1; Vasculogenesis

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; ACTIVIN RECEPTOR 1; ACVRL1 PROTEIN, MOUSE; MESSENGER RNA; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; PROTEIN EXPRESSION; SPROUTING; ANIMAL; BLOOD VESSEL; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KINETICS; METABOLISM; MOUSE; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; KINETICS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750565365     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0494     Document Type: Article

References (31)

1. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
2. Roberts AB, Sporn MB. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am Rev Respir Dis 1989;140:1126-1128.
3. Pepper MS. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
4. Goumans MJ, Valdimarsdottir G, Itoh S et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003;12:817-828.
5. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584.
6. Goumans MJ, Mummery C. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 2000;44:253-265.
7. McAllister KA, Grogg KM, Johnson DW et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-351.
8. Johnson DW, Berg JN, Baldwin MA et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-195.
9. Gallione CJ, Repetto GM, Legius E et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004;363:852-859.
10. Vittet D, Prandini MH, Berthier R et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996;88:3424-3431.
11. Feraud O, Cao Y, Vittet D. Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest 2001;81:1669-1681.
12. Tillet E, Vittet D, Feraud O et al. N-cadherin deficiency impairs pericyte recruitment, and not endothelial differentiation or sprouting, in embryonic stem cell-derived angiogenesis. Exp Cell Res 2005;310:392-400.
13. Nagy A, Rossant J, Nagy R et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 1993;90:8424-8428.
14. Feraud O, Prandini MH, Vittet D. Vasculogenesis and angiogenesis from in vitro differentiation of mouse embryonic stem cells. Methods Enzymol 2003;365:214-228.
15. Fujii M, Takeda K, Imamura T et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 1999;10:3801-3813.
16. Vittet D, Buchou T, Schweitzer A et al. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A 1997;94:6273-6278.
17. Li ZJ, Wang ZZ, Zheng YZ et al. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation. J Cell Biochem 2005;95:559-570.
18. Hirashima M, Kataoka H, Nishikawa S et al. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999;93:1253-1263.
19. Goumans MJ, Zwijsen A, van Rooijen MA et al. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 1999;126:3473-3483.
20. Dickson MC, Martin JS, Cousins FM et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995;121:1845-1854.
21. Gualandris A, Annes JP, Arese M et al. The latent transforming growth factor-beta-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium. Mol Biol Cell 2000;11:4295-4308.
22. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
23. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
24. Ng YS, Ramsauer M, Loureiro RM et al. Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies. Lab Invest 2004;84:1209-1218.
25. Pertovaara L, Kaipainen A, Mustonen T et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-6274.
26. Keller G, Kennedy M, Papayannopoulou T et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993;13:473-486.
27. Watabe T, Nishihara A, Mishima K et al. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol 2003;163:1303-1311.
28. Ota T, Fujii M, Sugizaki T et al. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol 2002;193:299-318.
29. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002;118:211-215.
30. Park KW, Morrison CM, Sorensen LK et al. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol 2003;261:251-267.
31. Lamouille S, Mallet C, Feige JJ et al. Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002;100:4495-4501.